Search Results - "TÜRK, Hacı Mehmet"

Diagnostic performance of apparent diffusion coefficient values for the differentiation of intrahepatic cholangiocarcinoma from gastrointestinal adenocarcinoma liver metastases by Yilmaz, Temel Fatih, Gultekin, Mehmet Ali, Turk, Hacı Mehmet, Besiroglu, Mehmet, Cesme, Dilek Hacer, Simsek, Melih, Alkan, Alpay, Toprak, Huseyin

“…We aimed to investigate whether there is a difference between intrahepatic cholangiocarcinoma (IHCC) and liver metastases of gastrointestinal system (GIS)…”
Get full text

Synchronous Hepatocellular Carcinoma and Cholangiocellular Carcinoma on 18F-FDG PET/CT by Erdoğan, Ezgi Başak, Türk, Hacı Mehmet, Tekçe, Ertuğrul, Aydın, Mehmet

“…A 43-year-old male patient presented with a mass lesion on the right liver lobe, segment 5, in radiological imaging and elevated alpha-fetoprotein levels (323…”
Get full text

Cutaneous Involvement of Lung Adenocarcinoma by CENGİZ, Fatma Pelin, TOSUNER, Zeynep, SÖNMEZ, Berkant, ŞEKER, Mesut, EMİROĞLU, Nazan, TÜRK, Hacı Mehmet, ONSUN, Nahide

Get full text

Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial by Wainberg, Zev A., Kang, Yoon-Koo, Lee, Keun-Wook, Qin, Shukui, Yamaguchi, Kensei, Kim, In-Ho, Saeed, Anwaar, Oh, Sang Cheul, Li, Jin, Turk, Haci Mehmet, Teixeira, Alexandra, Hitre, Erika, Udrea, Adrian A., Cardellino, Giovanni Gerardo, Sanchez, Raquel Guardeño, Zahlten-Kümeli, Anita, Taylor, Kate, Enzinger, Peter C.

“…Background We report the final results of the randomized phase 2 FIGHT trial that evaluated bemarituzumab, a humanized monoclonal antibody selective for…”
Get full text

Relationship between KRAS mutation and diffusion weighted imaging in colorectal liver metastases; Preliminary study by Gültekin, Mehmet Ali, Türk, Hacı Mehmet, Beşiroğlu, Mehmet, Toprak, Hüseyin, Yurtsever, Ismail, Yilmaz, Temel Fatih, Sharifov, Rasul, Uysal, Ömer

“…•Analyzing KRAS mutation is essential for colorectal liver metastases.•DWI is widely used in the detection and follow-up of CRLM.•ADC values were significantly…”
Get full text

Diffusion Tensor Imaging Can Discriminate the Primary Cell Type of Intracranial Metastases for Patients with Lung Cancer by Bilgin, Sabriye Sennur, Gultekin, Mehmet Ali, Yurtsever, Ismail, Yilmaz, Temel Fatih, Cesme, Dilek Hacer, Bilgin, Melike, Topcu, Atakan, Besiroglu, Mehmet, Turk, Haci Mehmet, Alkan, Alpay, Bilgin, Mehmet

“…Purpose: Histopathological differentiation of primary lung cancer is clinically important. We aimed to investigate whether diffusion tensor imaging (DTI)…”
Get full text

Relationship with Programmed Cell Death Ligand 1 (PD-L1) and DTI Features in Brain Metastases of Non-small Cell Lung Cancer: A Preliminary Study by Yilmaz, Temel Fatih, Yurtsever, Ismail, Turk, Hacı Mehmet, Gultekin, Mehmet Ali, Besiroglu, Mehmet, Cesme, Dilek Hacer, Shbair, Abdallah T M, Alkan, Alpay

“…The purpose of the study was to determine DTI properties of brain metastases in subjects with Non-Small Cell Lung Carcinoma (NSCLC) to evaluate whether there…”
Get more information

A propensity score‐matched comparison of neoadjuvant chemoradiotherapy with cisplatin‐5FU and carboplatin–paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study by Gürler, Fatih, Tay, Fatih, Sucuoğlu İşleyen, Zehra, Yerlikaya, Tahir, Hendem, Engin, Esen, Selin Aktürk, Sütçüoğlu, Osman, Işık, Deniz, Niğdelioğlu, Büşra, Özen, Miraç, Şahin, Elif, Şakalar, Teoman, Şengül Samancı, Nilay, Alan, Özkan, Hacıbekiroğlu, İlhan, Algın, Efnan, Yılmaz, Melek Karakurt, Türk, Hacı Mehmet, Öksüzoğlu, Berna, Yavuz, Aydın, Yüksel, Osman, Bora, Hüseyin, Yazıcı, Ozan, Özet, Ahmet, Özdemir, Nuriye

“…Background Neoadjuvant treatment is the standard treatment in locally advanced ESCC. However, the optimal chemotherapy regimen is not known. Method This is a…”
Get full text

Evaluation of toxic effects of chemotherapy in lung malignancies on cerebral white matter using diffusion tensor imaging by Aydin, Sinem, Demir, Tarik, Turk, Haci Mehmet, Cesme, Dilek Hacer, Aliyev, Altay, Ali Gultekin, Mehmet, Fatih Yilmaz, Temel, Alkan, Alpay

“…Non-small cell lung cancer (NSCLC) is a leading cause of morbidity and mortality. Carboplatin and cisplatin based regimens are used in the treatment of NSCLC…”
Get full text

First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer by Esen, Selin Akturk, Ergun, Yakup, Erol, Cihan, Arikan, Rukiye, Er, Muhammed Muhiddin, Atci, Muhammed Mustafa, Topcu, Atakan, Ucar, Gokhan, Akagunduz, Baran, Aykan, Musa Baris, Ozen, Mirac, Baytemur, Naziyet Kose, Ozcelik, Melike, Sahin, Elif, Guven, Denizcan, Menekse, Serkan, Ak, Naziye, Teker, Fatih, Kut, Engin, Sakalar, Teoman, Alan, Ozkan, Kacan, Turgut, Turhal, Nazim Serdar, Kilickap, Saadettin, Turker, Sema, Sendur, Mehmet Ali Nahit, Kostek, Osman, Karaagac, Mustafa, Sakin, Abdullah, Turk, Haci Mehmet, Caglayan, Dilek, Cihan, Sener, Acikgoz, Yusuf, Uncu, Dogan

“…Fluoropyrimidine+cisplatin/oxaliplatin+trastuzumab therapy is recommended for the first-line treatment of human epidermal growth factor receptor 2…”
Get full text

Report of a Case of Signet Ring Carcinoma Presenting as Gastric Mucosal Thickening: A Diagnostic Dilemma by KARATOPRAK, Cumali, AKÇAKAYA, Adem, ŞENTÜRK, Hakan, ÇOBAN, Ganime, ŞAHİN, Nurhan, TÜRK, Hacı Mehmet

“…The number of cancer cases has been increasing worldwide. Early diagnosis and tumor resection remain as the most effective treatments for gastric cancer…”
Get full text

Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial by Shah, Manish A., Shitara, Kohei, Ajani, Jaffer A., Bang, Yung-Jue, Enzinger, Peter, Ilson, David, Lordick, Florian, Van Cutsem, Eric, Gallego Plazas, Javier, Huang, Jing, Shen, Lin, Oh, Sang Cheul, Sunpaweravong, Patrapim, Soo Hoo, Hwoei Fen, Turk, Haci Mehmet, Oh, Mok, Park, Jung Wook, Moran, Diarmuid, Bhattacharya, Pranob, Arozullah, Ahsan, Xu, Rui-Hua

“…There is an urgent need for first-line treatment options for patients with human epidermal growth factor receptor 2 (HER2)-negative, locally advanced…”
Get full text

Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study by Wainberg, Zev A, Enzinger, Peter C, Kang, Yoon-Koo, Qin, Shukui, Yamaguchi, Kensei, Kim, In-Ho, Saeed, Anwaar, Oh, Sang Cheul, Li, Jin, Turk, Haci Mehmet, Teixeira, Alexandra, Borg, Christophe, Hitre, Erika, Udrea, Adrian A, Cardellino, Giovanni Gerardo, Sanchez, Raquel Guardeño, Collins, Helen, Mitra, Siddhartha, Yang, Yingsi, Catenacci, Daniel V T, Lee, Keun-Wook

“…Outcomes are poor in patients with HER2-negative, advanced gastric or gastro-oesophageal junction adenocarcinomas. In this study, we investigated efficacy and…”
Get full text

Synchronous Hepatocellular Carcinoma and Cholangiocellular Carcinoma on 18 F-FDG PET/CT by Erdoğan, Ezgi Başak, Türk, Hacı Mehmet, Tekçe, Ertuğrul, Aydın, Mehmet

“…A 43-year-old male patient presented with a mass lesion on the right liver lobe, segment 5, in radiological imaging and elevated alpha-fetoprotein levels (323…”
Get full text

Synchronous Hepatocellular Carcinoma and Cholangiocellular Carcinoma on ^sup 18^F-FDG PET/CT by Erdoğan, Ezgi Başak, Türk, Hacı Mehmet, Tekçe, Ertuğrul, Aydın, Mehmet

“…A 43-year-old male patient presented with a mass lesion on the right liver lobe, segment 5, in radiological imaging and elevated alpha-fetoprotein levels (323…”
Get full text

Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram by Yasin, Ayse Irem, Uluganyan, Mahmut, Isleyen, Zehra Sucuoglu, Topcu, Atakan, Shbair, Abdallah Tm, Simsek, Melih, Besiroglu, Mehmet, Ersoy, Yeliz Emine, Türk, Hacı Mehmet, Seker, Mesut

“…Objective We aimed to evaluate cardiac safety profile of ribociclib with 24-h rhythm Holter ECG. Material and method Forty-two female metastatic breast cancer…”
Get full text

A comparison of anticholinergic burden in older patients with and without cancer by Yasin, Ayse Irem, Topcu, Atakan, Akuc, Meysere Nur, Türk, Hacı Mehmet, Soysal, Pinar

“…To compare anticholinergic burden (ACB) in older patients with and without cancer and evaluate the effects of ACB on geriatric syndromes. A total of 291…”
Get full text

The efficacy of BNT162b2 (Pfizer–BioNTech) and CoronaVac vaccines in patients with cancer by Simsek, Melih, Yasin, Ayse I., Besiroglu, Mehmet, Topcu, Atakan, Sucuoglu Isleyen, Zehra, Seker, Mesut, Turk, Haci Mehmet

“…Although vaccination is efficacious and prevents infection in the general population, there is limited data about Coronavirus disease‐19 (Covid‐19) occurrence…”
Get full text

Comparison of different decision support software programs in perspective of potential drug–drug interactions in the oncology clinic by Bektay, Muhammed Yunus, Seker, Zehra, Eke, Hatice Kubra, Turk, Haci Mehmet, Izzettin, Fikret Vehbi

“…Introduction One of the most intriguing situations for healthcare providers is cancer therapy. Drug-drug interactions (DDIs) account for 20–30% of all adverse…”
Get full text

Anxiety levels of breast cancer patients in Turkey during the COVID-19 pandemic by Yasin, Ayse Irem, Topcu, Atakan, Shbair, Abdallah TM, Isleyen, Zehra Sucuoglu, Ozturk, Ahmet, Besiroglu, Mehmet, Türk, Hacı Mehmet

“…To assess the anxiety levels of breast cancer patients during the COVID-19 pandemic. A total of 298 patients completed the State-Trait Anxiety Inventory…”
Get full text